H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancer

γH2AX Assay as DNA Damage Biomarker for Human Population Studies: Defining Experimental Conditions

(2015) María Sánchez-Flores et al.   TOXICOLOGICAL SCIENCES

Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study

(2014) Angeline S. Andrew et al.   BJU INTERNATIONAL

Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use?

(2014) Francesca Sanguedolce et al.   CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES

Molecular markers for urothelial bladder cancer prognosis: Toward implementation in clinical practice

(2014) Bas W.G. van Rhijn et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

DNA Double Strand Break Repair: A Radiation Perspective

(2013) Joy N. Kavanagh et al.   ANTIOXIDANTS & REDOX SIGNALING

Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study

(2013) Elizabeth Tracey et al.   BJU INTERNATIONAL

Risk Assessment of Esophageal Adenocarcinoma Using  -H2AX Assay

(2013) E. Xu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Ionizing Radiation-Induced  -H2AX Activity in Whole Blood Culture and the Risk of Lung Cancer

(2013) Y. He et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

 -H2AX level in peripheral blood lymphocytes as a risk predictor for bladder cancer

(2013) M. I. Fernandez et al.   CARCINOGENESIS

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

(2013) Marko Babjuk et al.   EUROPEAN UROLOGY

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

(2013) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Polymorphisms in theXRCC1gene modify survival of bladder cancer patients treated with chemotherapy

(2013) Carlotta Sacerdote et al.   INTERNATIONAL JOURNAL OF CANCER

γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies

(2013) Vanessa Valdiglesias et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder

(2013) Evanguelos Xylinas et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder

(2012) Georgios Gakis et al.   EUROPEAN UROLOGY

DNA Double-Strand Break Analysis by γ-H2AX Foci: A Useful Method for Determining the Overreactors to Radiation-Induced Acute Reactions Among Head-and-Neck Cancer Patients

(2012) Hassan Venkatesh Goutham et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities

(2012) David W. Chang et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research

(2011) Alesia Ivashkevich et al.   CANCER LETTERS

XRCC1 codon 399 mutant allele: A risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy

(2010) Rama Devi Mittal et al.   CANCER BIOLOGY & THERAPY

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

(2010) A. Choudhury et al.   CANCER RESEARCH

ERCC1 haplotypes modify bladder cancer risk: A case–control study

(2010) Fulvio Ricceri et al.   DNA REPAIR

Differences in the kinetics of γ-H2AX fluorescence decay after exposure to low and high LET radiation

(2010) Thomas E. Schmid et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Spatiotemporal characterization of ionizing radiation induced DNA damage foci and their relation to chromatin organization

(2010) S.V. Costes et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

A novel XPF −357A>C polymorphism predicts risk and recurrence of bladder cancer

(2010) M Wang et al.   ONCOGENE

Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

(2009) Richard J. Sylvester et al.   EUROPEAN UROLOGY

The response ofgamma-H2AX in human lymphocytes and lymphocytes subsets measured in whole blood cultures

(2009) Andrei Andrievski et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Phosphorylated H2AX in Noninvasive Low Grade Urothelial Carcinoma of the Bladder: Correlation With Tumor Recurrence

(2009) Wang L. Cheung et al.   JOURNAL OF UROLOGY

Combination of Multiple Molecular Markers Can Improve Prognostication in Patients With Locally Advanced and Lymph Node Positive Bladder Cancer

(2009) Shahrokh F. Shariat et al.   JOURNAL OF UROLOGY

A rapid flow cytometry test based on histone H2AX phosphorylation for the sensitive and specific diagnosis of ataxia telangiectasia

(2008) Paola Porcedda et al.   CYTOMETRY PART A

 -H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin

(2008) A. Kinner et al.   NUCLEIC ACIDS RESEARCH

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

(2007) Shahrokh F. Shariat et al.   CANCER